Cancer in the oropharynx: Cost calculation of different treatment modalities for controlled primaries, relapses and grade III/IV complications

Radiotherapy and Oncology

Volumn 77, Issue 1, 2005, Pages 65-72

  Nijdam, Wideke ^a   Levendag, Peter ^a   Noever, Inge ^a   Uyl De Groot, Carin ^a   Van Agthoven, Michel ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Brachytherapy; Costs; External beam radiation therapy; Grade III IV complications; Oropharyngeal cancer; Surgery; Tumor control

Indexed keywords

AMIFOSTINE; CISPLATIN; FLUOROURACIL; PACLITAXEL;

ADULT; AGED; ARTICLE; BEAM THERAPY; BRACHYTHERAPY; CALCULATION; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL PROTOCOL; CONTROLLED STUDY; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HOSPITAL ADMISSION; HOSPITAL COST; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL COMPUTING; NECK DISSECTION; ORGAN PRESERVATION; OROPHARYNX CANCER; PATIENT CARE; PATIENT SELECTION; POSTOPERATIVE CARE; PRIORITY JOURNAL; RELAPSE; SALVAGE THERAPY; SURVIVAL TIME; ULCER; UNIVERSITY HOSPITAL;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; CISPLATIN; COST-BENEFIT ANALYSIS; FEMALE; FLUOROURACIL; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OROPHARYNGEAL NEOPLASMS; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 27144446148     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2005.09.007     Document Type: Article

References (18)

1. G. Calais, E. Bardet, and C. Sire Radiotherapy with concomitant weekly docetaxel for stages III/IV oropharynx carcinoma. Results of the 8-02 gortec phase II trial Int J Radiat Oncol Biol Phys 58 2004 161 166
2. M.F. Drummond, B.J. O'Brien, G.L. Stoddart, and G.W. Torrance Methods for the economic evaluation of health care programmes 1996 Oxford University Press New York
3. K.K. Fu, T.F. Pajak, and A. Trotti A Radiation Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation for head and neck squamous cell carcinomas: first report of RTOG 9003 Int J Radiat Oncol Biol Phys 48 2000 7 16
4. M.R. Gold, J.E. Siegel, L.B. Russell, and M.C. Weinstein Cost-effectiveness in health and medicine 1996 Oxford University Press New York
5. P.C. Levendag, W.M. Nijdam, and M. van Agthoven Chemotherapy and high-dose-rate brachytherapy in the management of advanced cancers of the nasopharynx: clinical impact of high technology: is it worth the cost? Brachytherapy 1 2002 11 20
6. P.C. Levendag, W.M. Nijdam, and M. van de Pol Brachytherapy versus surgery in carcinoma of the tonsillar fossa and/or soft palate: late normal tissue sequelae and performance status. Can we be more selective? Int J Radiat Oncol Biol Phys 59 2004 713 724
7. P.C. Levendag, P.I.M. Schmitz, and P.P. Jansen Fractionated high-dose-rate and pulsed-dose-rate brachytherapy: first clinical experience in squamous cell carcinoma of the tonsillar fossa and soft palate Int J Radiat Oncol Biol Phys 38 1997 497 506
8. M. List, C. Ritter-Ster, and S. Lansky A performance status scale for head and neck cancer patients Cancer 66 1990 564 569
9. M.A. List, J.L. Rutherford, and J. Stracks Prioritizing treatment outcomes: head and neck cancer patients versus nonpatients Head Neck 26 2004 163 170
10. M.A. List, J. Stracks, and L. Colangelo How do head and neck cancer patients prioritize treatment outcomes before initiating treatment J Clin Oncol 18 2000 877 884
11. W.M. Nijdam, P.C. Levendag, and I. Noever Cost analysis comparing brachytherapy versus surgery for primary carcinoma of the tonsillar fossa and/or soft palate Int J Radiat Oncol Biol Phys 59 2004 488 494
12. J.B. Oostenbrink, M.A. Koopmanschap, and F.F.H. Rutten Manual for costing research 2000 Health Care Board Amstelveen [in Dutch]
13. B. O'Sullivan, P. Warde, and B. Grice The benefits and pitfalls of ipsilateral radiotherapy in carcinoma of the tonsillar region Int J Radiat Oncol Biol Phys 51 2001 332 342
14. J.T. Parsons, W.M. Mendenhall, and S.P. Stringer Squamous cell carcinoma of the oropharynx: surgery, radiation therapy, or both Cancer 94 2002 2967 2980
15. Pol van de M, Levendag PC, De Bree RR et al. Radical radiotherapy compared with surgery for advanced squamous cell carcinoma of the base of tongue. Brachytherapy; in press.
16. M. Van Agthoven, B.M. van Ineveld, and M.F. de Boer The costs of head and neck oncology: primary tumours, recurrent tumours and long-term follow-up Eur J Cancer 37 2001 2204 2211
17. H.R. Withers, L.J. Peters, and J.M.G. Taylor Late normal tissue sequelae from radiation therapy for carcinoma of the tonsil: patterns of fractionation, study of radiobiology Int J Radiat Oncol Biol Phys 33 1995 563 568
18. H.R. Withers, L.J. Peters, and J.M.G. Taylor Local control of carcinoma of the tonsil by radiation therapy: an analysis of patterns of fractionation in nine institutions Int J Radiat Oncol Biol Phys 33 1995 549 562